KALV•benzinga•
KalVista Pharmaceuticals Announces Early Completion Of Enrollment In KONFIDENT-KID Pediatric HAE Trial; First Data Presentation Expected Before Year-end; sNDA Submission By Mid-2026
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 25, 2025 by benzinga